Zogenix Inc. buy marge
Start price
07.09.18
/
50%
€40.27
Target price
04.11.21
€79.00
Performance (%)
-66.60%
End price
05.11.21
€13.45
Summary
This prediction ended on 05.11.21 with a price of €13.45. Massive losses of -66.60% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % | 60,42 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % | 87,82 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % | 66,93 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % | 60,46 % |
Comments by marge for this prediction
In the thread Zogenix Inc. diskutieren
Zogenix mit Aufwärtspotential
Zogenix with positive results from a Phase 2 clinical trial evaluating ZX008 in patients with Lennox-Gastaut syndrome (LGS), a rare and severe type of childhood epilepsy.
Zogenix initiated with Buy rating and $116 (154% upside) price target at B. Riley FBR citing upside for ZX008.
In the thread Trading Zogenix Inc.
Die von marge gewählte maximale Laufzeit wurde überschritten